A detailed history of State Of Wyoming transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, State Of Wyoming holds 6,079 shares of PCRX stock, worth $120,546. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,079
Previous 5,445 11.64%
Holding current value
$120,546
Previous $155,000 41.29%
% of portfolio
0.01%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $7,417 - $18,043
634 Added 11.64%
6,079 $91,000
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $10,786 - $13,328
423 Added 8.42%
5,445 $155,000
Q1 2024

May 13, 2024

BUY
$27.7 - $35.48 $93,930 - $120,312
3,391 Added 207.91%
5,022 $146,000
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $43,112 - $56,199
-1,638 Reduced 50.11%
1,631 $55,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $72,374 - $94,572
2,359 Added 259.23%
3,269 $100,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $7,368 - $9,690
204 Added 28.9%
910 $36,000
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $3,517 - $4,294
99 Added 16.31%
706 $28,000
Q4 2022

Feb 14, 2023

SELL
$38.19 - $57.45 $74,088 - $111,453
-1,940 Reduced 76.17%
607 $23,000
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $31,358 - $36,040
612 Added 31.63%
2,547 $136,000
Q2 2022

Aug 15, 2022

SELL
$51.49 - $81.64 $24,509 - $38,860
-476 Reduced 19.74%
1,935 $113,000
Q1 2022

May 13, 2022

BUY
$60.03 - $76.49 $5,942 - $7,572
99 Added 4.28%
2,411 $184,000
Q4 2021

Feb 11, 2022

BUY
$47.97 - $62.21 $10,025 - $13,001
209 Added 9.94%
2,312 $139,000
Q3 2021

Feb 11, 2022

BUY
$54.64 - $61.3 $20,544 - $23,048
376 Added 21.77%
2,103 $118,000
Q2 2021

Feb 11, 2022

BUY
$59.18 - $69.99 $102,203 - $120,872
1,727 New
1,727 $105,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $909M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.